CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research aims to develop multifunctional nanomaterials for the diagnosis and treatment of Alzheimer's disease. It focuses on using ultrasmall gold nanoclusters for imaging amyloid aggregates and delivering anti-amyloid drugs non-invasively.
Neurodegenerative diseases are a global epidemic with significant health, social and economic implications and despite intensive research, there is still no cure for them.
Alzheimers disease (AD) is the most prevalent neurological disorder having symptoms of the progressive memory loss, neuronal cell death, loss of immune response and cognitive function, eventually leading to patient death.
Amyloid- (A) protein is the main neuropathic agent in AD and aggregation of A plaques are found in the bra…
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
UNIVERSITE LYON 1 CLAUDE BERNARD
France, Villeurbanne Cedex
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, GRENOBLE
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
